Home › Research › Treatments
The Impact of Immunotherapy Drugs on the Human Nervous System
Zihan Shi, Jinwei Xiang. MedScien, 2025-06-26
Topic: Brain proteins, microglia and lab models
Plain-language summary
Immunotherapy is rapidly becoming one of the most promising directions in the modern approach to cancer treatment. CAR-T cell therapy, immune checkpoint inhibitors, monoclonal antibodies, and gene therapies have shown great potential in enhancing the quality of life of patients, through the activation of the body’s immune system against cancerous cells. In addition to cancer, immunotherapy is being tested in neurodegenerative and neuroinflammatory disorders such as multiple sclerosis and Alzheimer disease. However, these therapies entail certain risks especially with regard to the nervous system. There is increasing evidence that immunotherapies are associated with neurotoxic side effects such as neuroinflammation, encephalitis, cognitive decline and peripheral neuropathy which can greatly affect patient’s quality of life. This review focuses on the description of these immunotherapies’ mechanisms and clinical use as well as their impact on the CNS and PNS adverse effects. Measures that can help avoid these risks include precision medicine, better gene delivery vectors, and selective treatment approaches, which are very helpful in maximizing the safety and efficacy of immunotherapy. One of the critical issues of further development of these novel therapeutic interventions is the optimization of desired therapeutic outcomes and possible neurological adverse effects.
What this study adds
Evidence grade: Low
This review notes that immunotherapy is being tested in Alzheimer's disease but that immunotherapies are associated with neurotoxic side effects such as neuroinflammation, encephalitis, cognitive decline, and peripheral neuropathy. It reports no evidence that immunotherapy cures or prevents Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Shi, Z., & Xiang, J. (2025). The Impact of Immunotherapy Drugs on the Human Nervous System. MedScien. https://doi.org/10.61173/mz7bfr42
Vancouver
Shi Z, Xiang J. The Impact of Immunotherapy Drugs on the Human Nervous System. MedScien. 2025. doi:10.61173/mz7bfr42.
BibTeX
@article{shi2025-63a87f31,
author = {Shi, Zihan and Xiang, Jinwei},
title = {{The Impact of Immunotherapy Drugs on the Human Nervous System}},
journal = {MedScien},
year = {2025},
doi = {10.61173/mz7bfr42},
url = {https://doi.org/10.61173/mz7bfr42}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- There is increasing evidence that immunotherapies are associated with neurotoxic side effects such as neuroinflammation, encephalitis, cognitive decline and peripheral neuropathy which can greatly affect patient’s quality of life.
Why it matters
This review notes that immunotherapy is being tested in Alzheimer's disease but that immunotherapies are associated with neurotoxic side effects such as neuroinflammation, encephalitis, cognitive decline, and peripheral neuropathy. It reports no evidence that immunotherapy cures or prevents Alzheimer's disease.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Evidence strengthLow
How this study scored 28/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 27 of the 96 points we could judge it on, which is 28 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (MedScien) |
| Journal's citation record | 0 / 4 | MedScien: journal h-index 3 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | 1 / 3 | University of Delaware: institution h-index 738 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 2 countries |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Points | 27 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 27 of the 96 points we could judge it on is 28 out of 100. |
| Total | 28 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Treatments from nearby years
Also in Treatments
201 studies in the library are filed under Treatments with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Treatments hub.